Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Randomized, Double-blind, Placebo-controlled Trial to Investigate the Anti-inflammatory Effects of Frondanol in Adults With Inflammatory Bowel Disease

NCT05194007 is registered in ClinicalTrials.gov with Mohammed Bin Rashid University of Medicine and Health Sciences as lead sponsor.

NCT NCT05194007
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05194007 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Randomized, Double-blind, Placebo-controlled Trial to Investigate the Anti-inflammatory Effects of Frondanol in Adults With Inflammatory Bowel Disease
Lead sponsor
Mohammed Bin Rashid University of Medicine and Health Sciences
Phase
Phase 2/3
Overall status
Completed
Start date
February 19, 2022
Completion date
November 19, 2024
Enrollment
13 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

crohn colitis, ulcerative colitis chronic mild, ulcerative colitis chronic moderate